92 , 93 In a randomized study, headache was more frequent in patients receiving latanoprost than in those receiving bimatoprost although this difference did not reach statistical significance. 6 Patients with no prior history of migraine and/or headache have reported migraine after receiving latanoprost treatment. 62 Bimatoprost is classified as a category C drug according to the use-in-pregnancy ratings of the FDA.
1
—
—